http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112015021450-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2901e694724c2a759f619944cb7d2a4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 |
| filingDate | 2014-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ef941661daf97ffa6c542b6480371ef |
| publicationDate | 2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-112015021450-A2 |
| titleOfInvention | cabazitaxel and its use to treat metastatic prostate cancers |
| abstract | Cabazitaxel and its use for treatment of metastatic prostate cancers The present invention relates to the compound having the following formula: (i), which may be in a base form or as a a hydrate or solvate, and in combination with prednisone or prednisolone, for use in the treatment of hormone refractory castration-resistant or metastatic prostate cancer in patients without risk of developing gastrointestinal disorders from the group consisting of: bleeding and gastrointestinal perforation, gastritis, enterocolitis, neutropenic enterocolitis, colitis, intestinal obstruction, and ileum. |
| priorityDate | 2013-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.